{"gene":"GNAS","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1999,"finding":"The Gnas locus encodes multiple oppositely imprinted transcripts (Gnasxl, Nesp/NESP55, and Gnas) within a single transcription unit; Gnasxl and Nesp transcripts are alternatively spliced onto exon 2 of Gnas. Gnasxl is maternally methylated and paternally expressed, whereas Nesp is paternally methylated and maternally expressed.","method":"Representational difference analysis based on parent-of-origin methylation differences; RT-PCR and Northern blot in interspecific mouse crosses","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal imprinting confirmed by multiple orthogonal methods (RDA, RT-PCR, Northern blot) and replicated across subsequent studies","pmids":["10097123"],"is_preprint":false},{"year":1997,"finding":"NESP55 (encoded by the GNAS locus, maternally expressed) is a chromogranin-like acidic protein localized to large dense-core secretory vesicles in neuroendocrine tissues; it is proteolytically processed within chromaffin granules to smaller peptides, including the tetrapeptide LSAL (flanked by prohormone convertase cleavage sites), which acts as an endogenous 5-HT1B receptor antagonist.","method":"Molecular cloning; immunoblot; immunofluorescence; 1D/2D gel electrophoresis of secretory proteins from chromaffin granules","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct biochemical characterization with multiple orthogonal methods; replicated in subsequent studies confirming secretory granule localization","pmids":["9111083"],"is_preprint":false},{"year":2000,"finding":"A paternal-allele-specific antisense transcript (Nespas/Gnas-as) originates ~2.2 kb upstream of the Gnasxl promoter and spans the Nesp region; it is expressed exclusively from the paternal allele in most tissues, suggesting a cis-regulatory role in imprinting of the Nesp sense transcript.","method":"Strand-specific RT-PCR; Northern blot analysis in embryos carrying uniparental disomy for distal Chr 2","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — parental allele specificity confirmed by uniparental disomy embryos with strand-specific RT-PCR; independently replicated","pmids":["10716699"],"is_preprint":false},{"year":2000,"finding":"NESP55 mRNA is alternatively spliced in a tissue-specific manner onto Gsα exons 2–13 (adrenal, pituitary, brain) or onto exons 2, 3, N1 (pituitary); the protein is posttranslationally modified by keratan sulfate glycosaminoglycan addition and differentially processed by endopeptidases in various tissues.","method":"cDNA cloning, RT-PCR, Northern blot, protein sequencing","journal":"Neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in a single lab confirming splice variants and PTM","pmids":["10729789"],"is_preprint":false},{"year":2002,"finding":"NESP55 undergoes fast anterograde axonal transport in peripheral neurons and is slowly proteolytically processed to smaller peptides (including GAIPIRRH) during transport; it is not retrogradely transported and is absent from terminal regions.","method":"Crush-operated sciatic nerve experiments; immunohistochemistry; HPLC-radioimmunoassay","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo localization with nerve crush and biochemical analysis; single lab, two orthogonal methods","pmids":["11934480"],"is_preprint":false},{"year":2003,"finding":"The Nesp and Gnasxl promoter regions are embedded in extensive CpG islands with allele-specific methylation (paternal methylation at Nesp; maternal methylation at Gnasxl). Parental allele-specific DNase I-hypersensitive sites correlate with the hypomethylated (active) allele. A germline methylation mark covering Gnasxl and Nespas promoters was identified, suggesting separate control from the Gnas promoter.","method":"Bisulfite sequencing; DNase I hypersensitivity assay in gametes, ES cells, and tissues","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal epigenetic methods (bisulfite sequencing + DNase I) across developmental stages; replicated by subsequent studies","pmids":["12897124"],"is_preprint":false},{"year":2004,"finding":"Gsα (encoded by GNAS) couples seven-transmembrane receptors to adenylyl cyclase to generate cAMP. Somatic activating mutations at residues R201 and Q227 (which impair the GTPase turn-off reaction) cause constitutive adenylyl cyclase activation, found in endocrine tumors, fibrous dysplasia, and McCune-Albright syndrome. Heterozygous inactivating mutations cause Albright hereditary osteodystrophy, with hormone resistance only on maternal inheritance due to tissue-specific maternal-allele-predominant expression.","method":"Biochemical characterization of GTPase activity; genetic analysis; mouse knockout models","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — enzymatic mechanism (GTPase impairment) established by in vitro assays; replicated across many labs and confirmed in multiple disease models","pmids":["15331575"],"is_preprint":false},{"year":2005,"finding":"Gsα deficiency from maternal allele (via exon 1 deletion) causes obesity and insulin resistance, phenotypically distinct from paternal exon 2 deletion. The lean, hypermetabolic, insulin-sensitive phenotype of paternal exon 2 deletion mice results from XLαs (Gnasxl product) deficiency, not Gsα loss. Thus, Gsα and XLαs have opposite effects on energy/glucose metabolism.","method":"Targeted gene deletion of Gnas exon 1 in mice; metabolic phenotyping; comparison with exon 2 mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using multiple allele-specific knockouts; phenotypic readouts (body weight, insulin sensitivity, metabolic rate) in vivo","pmids":["15883378"],"is_preprint":false},{"year":2005,"finding":"Knockout of Nesp55 in mice produces no metabolic or developmental defect but causes abnormal reactivity to novel environments (hyperreactivity in three behavioral tasks) independent of general locomotion and anxiety, associated with prominent Nesp55 expression in the noradrenergic locus coeruleus.","method":"Gene targeting knockout; behavioral assays (open field, elevated plus maze, light-dark box)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with specific behavioral phenotypes; replicated in follow-up behavioral studies","pmids":["15798190"],"is_preprint":false},{"year":2006,"finding":"A paternally derived targeted deletion of the germline differentially methylated region (DMR) associated with the antisense Nespas transcript (Nespas DMR) unexpectedly abolishes expression of all transcripts in the Gnas cluster and methylation of two downstream DMRs, establishing the Nespas DMR as the principal imprinting control region (ICR) that acts bidirectionally to switch expression between Gnasxl and Gnas.","method":"Targeted deletion in mice; allele-specific RT-PCR; bisulfite methylation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo targeted deletion with allele-specific expression and methylation analysis; published in high-impact journal with rigorous controls","pmids":["16462745"],"is_preprint":false},{"year":2010,"finding":"Targeted deletion of the region equivalent to the NESP55 DMR (delNesp55) on the maternal allele causes loss of all maternal Gnas methylation imprints; in kidney this leads to increased 1A transcription, decreased Gsα mRNA, and hypocalcemia/hyperphosphatemia/secondary hyperparathyroidism, establishing the Nesp55 DMR as an additional principal ICR directing Gnas methylation.","method":"Mouse knock-in/deletion model; bisulfite methylation analysis; quantitative RT-PCR; serum calcium/phosphate measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo allele-specific deletion with methylation, expression, and biochemical phenotype readouts in a single rigorous study","pmids":["20427744"],"is_preprint":false},{"year":2011,"finding":"The paternally expressed macroRNA Nespas silences Nesp in cis via chromatin modification (reduced H3K4me3 demethylation and H3K36me3 depletion at the Nesp promoter), independent of DNA methylation, demonstrating that Nespas-mediated silencing can precede and is mechanistically separable from somatic DNA methylation.","method":"Nespas hypomorph knock-in allele; ChIP for histone modifications; bisulfite methylation analysis; allele-specific RT-PCR","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal chromatin and expression methods in a controlled knock-in model","pmids":["21455290"],"is_preprint":false},{"year":2015,"finding":"Nespas transcript/transcription across the ~2.6 kb region encompassing the Nesp promoter is necessary and sufficient for DNA methylation of the Nesp DMR; higher levels of Nespas are required for methylation than for transcriptional downregulation of Nesp. Nespas is strictly cis-acting even at supraphysiological levels.","method":"Knock-in alleles truncating Nespas upstream and downstream of Nesp promoter; bisulfite methylation; allele-specific RT-PCR","journal":"Non-coding RNA","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic dissection with two independent knock-in alleles; single lab","pmids":["29861426"],"is_preprint":false},{"year":2015,"finding":"On the paternal allele, ectopic transcription of Nesp traversing the intragenic Exon1A DMR causes somatic de novo methylation of that DMR and de-repression of Gnas, demonstrating that transcription-driven de novo CpG methylation of an intragenic island can occur in somatic (non-germline) tissues.","method":"Mutant mouse models with ectopic Nesp expression on paternal allele; bisulfite methylation; allele-specific RT-PCR; phenotypic analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic model with orthogonal methylation and expression assays; single lab","pmids":["25659103"],"is_preprint":false},{"year":2013,"finding":"Gene dosage analysis in PatDp(dist2) mice shows that oedema is caused by loss of imprinted Gnas expression alone, while the full hyperactive/chunky/lethal phenotype requires combination of double-dose Gnasxl and absent imprinted Gnas, demonstrating antagonistic actions of Gsα and XLαs in multiple tissues including glucose homeostasis.","method":"Targeted mutations combined with uniparental disomy; metabolic/behavioral phenotyping; glucose measurements","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dose manipulation with multiple allele combinations; multiple phenotypic readouts; replication of core Gsα/XLαs antagonism finding","pmids":["23822972"],"is_preprint":false},{"year":2017,"finding":"Conditional knock-in of the activating GNAS R201H (fibrous dysplasia) mutation in osteochondral progenitors, osteoblasts, or bone marrow stromal cells (BMSCs) causes fibrous dysplasia features; the mechanism involves up-regulation of Wnt/β-catenin signaling, and removal of one Lrp6 copy significantly rescues the phenotype.","method":"Conditional knock-in mouse model; histology; Western blot; genetic rescue (Lrp6 heterozygosity)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knock-in with genetic epistasis rescue; multiple cell-type experiments","pmids":["29158412"],"is_preprint":false},{"year":2012,"finding":"At early stages of osteogenesis, increased cAMP signaling (mimicking activating GNAS mutation as in fibrous dysplasia) inhibits osteoblast differentiation and enhances adipogenesis partly by blocking BMP-Smad pathway signaling; inhibition of cAMP (as in inactivating GNAS mutations/POH) enhances osteoblast differentiation by stimulating BMP signaling.","method":"Pluripotent mouse ES cell osteogenic differentiation assay; pharmacological cAMP modulation (forskolin, 2',5'-dideoxyadenosine); BMP-Smad pathway readouts","journal":"Hormone and metabolic research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro differentiation assay with pharmacological tools and pathway readout; single lab","pmids":["22903279"],"is_preprint":false},{"year":2021,"finding":"GNAS mutations that cause obesity differentially impair MC4R (melanocortin 4 receptor) signaling, growth hormone-releasing hormone receptor signaling, and thyrotropin receptor signaling, explaining clinical heterogeneity; the obesity phenotype is mechanistically linked to defective MC4R/Gsα-mediated cAMP generation.","method":"Exome sequencing; functional GPCR signaling assays (cAMP production) for each mutation; clinical correlation with receptor-specific signaling","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro functional assays for multiple GPCR pathways with genotype-phenotype correlation in a large patient cohort","pmids":["34614324"],"is_preprint":false},{"year":2022,"finding":"Splicing factor mutations (U2AF1 and SRSF2) in MDS promote a long isoform of GNAS (GNAS-L) that encodes a hyperactive Gαs-L protein. GNAS-L activates ERK/MAPK signaling (not only cAMP), and MDS cells with SF mutations are sensitive to MEK inhibitors.","method":"RNA-seq; eCLIP in isogenic iPSC-derived hematopoietic stem/progenitor cells; biochemical cAMP/ERK assays; MEK inhibitor sensitivity assays","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — convergent RNA-seq and eCLIP evidence plus functional biochemical assays and pharmacological sensitivity in isogenic models","pmids":["34620690"],"is_preprint":false},{"year":2023,"finding":"The NESP55 imprinting control region (NESP-ICR) is required for DNA methylation and transcriptional silencing of the GNAS A/B region on the maternal allele; the STX16-ICR acts as a long-range enhancer of NESP55 transcription from the maternal allele, and this enhancer activity is enabled by direct binding of pluripotency factors in an embryonic stage-specific manner.","method":"CRISPR/Cas9 ICR deletions in human embryonic stem cells; allele-specific methylation and expression analysis; chromatin immunoprecipitation for pluripotency factor binding","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — CRISPR deletion in hESC model with allele-specific methylation, expression, and ChIP; multiple orthogonal methods in a single rigorous study","pmids":["36853809"],"is_preprint":false},{"year":2023,"finding":"GPR176 recruits GNAS intracellularly via its transmembrane helix 3-intracellular loop 2 domain; the GPR176/GNAS complex activates cAMP/PKA signaling and inhibits mitophagy through the cAMP/PKA/BNIP3L axis in colorectal cancer cells.","method":"Co-immunoprecipitation; homology modeling; cAMP measurements; mitophagy assays; genetic mouse models of CRC with Gpr176-deficiency","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP binding confirmed with domain modeling; functional pathway confirmed in vivo; single lab","pmids":["36905238"],"is_preprint":false},{"year":2016,"finding":"Nesp55 protein is co-localized with serotonin in midbrain neurons; mice lacking Nesp55 show impulsive choice behavior and reduced mRNA expression of serotonergic genes (Tph2, Slc6a4) in midbrain regions, implicating Nesp55 in regulation of the serotonin system and impulse control.","method":"Nesp55 knockout mouse (Nespm/+); delayed reinforcement task; stop-signal reaction time task; immunofluorescence co-localization; qPCR","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO mouse with specific behavioral assays and co-localization; single lab, two orthogonal methods","pmids":["27509352"],"is_preprint":false},{"year":2022,"finding":"Oncogenic GNAS R201C/H mutations drive cAMP/PKA signaling and activate β-catenin phosphorylation and Wnt/β-catenin target genes in colorectal cancer cells; GNAS knockout reduces tumor growth in peritoneal models, and chemical inhibition of PKA or β-catenin reduces organoid growth, demonstrating oncogene addiction.","method":"CRISPR/Cas9 GNAS knockout in CRC cell lines; 2D/3D organoid growth assays; xenograft mouse models; cAMP measurements; molecular profiling (western blot, PKA/β-catenin inhibitors)","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with in vivo xenograft and in vitro pharmacological pathway dissection; single lab","pmids":["35879396"],"is_preprint":false},{"year":2019,"finding":"Mutant GNAS R201H in IPMN-associated pancreatic cancer cells promotes mucin production (MUC2, MUC5AC/B) and limits tumor aggressiveness by negatively regulating NOTCH signaling via the GNAS-PKA pathway; PKA inhibition induces NOTCH intracellular domain (NICD) in GNAS-mutant cells, while GNAS wild-type cells show higher NICD levels and invasive capacity.","method":"CRISPR/Cas9 GNAS R201H silencing; xenograft experiments; western blot; transcriptome analysis; nuclear fractionation for NICD; PKA inhibitor treatment","journal":"Journal of gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR manipulation in primary cells with xenograft and molecular pathway analysis; single lab","pmids":["35018527"],"is_preprint":false},{"year":2020,"finding":"GNAS knockdown in HCC cells inhibits LPS-induced IL-6 expression by suppressing STAT3 activation; mechanistically, GNAS promotes STAT3 activation by inhibiting the long non-coding RNA TPTEP1 which interacts with STAT3. LPS stimulation increases GNAS expression through increased m6A methylation of GNAS mRNA.","method":"siRNA knockdown; ELISA; RNA-binding protein immunoprecipitation (RIP) for m6A; transcription factor profiling array; subcutaneous xenograft mouse model","journal":"Cellular & molecular biology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, mechanism inferred from indirect assays; GNAS-STAT3-TPTEP1 pathway not reconstituted directly","pmids":["32123532"],"is_preprint":false},{"year":2024,"finding":"PRKDC recruits and binds GDE2 to enhance the stability of GNAS protein; elevated GNAS subsequently activates AKT phosphorylation and confers doxorubicin resistance in osteosarcoma. Combined PRKDC inhibition (AZD7648) and doxorubicin synergistically suppresses osteosarcoma growth.","method":"CRISPR kinome screen; Co-IP of PRKDC/GDE2/GNAS; protein stability assays; xenograft mouse models; human organoids","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP interaction and in vivo/organoid functional validation; single lab","pmids":["38900943"],"is_preprint":false},{"year":1999,"finding":"NESP55 is preferentially localized in adrenaline-synthesizing (adrenergic) chromaffin cells of the adrenal medulla, co-localizing with phenylethanolamine-N-methyltransferase; noradrenergic cells contain ~5-fold lower levels. NESP55 mRNA distribution mirrors preproenkephalin mRNA, restricted to adrenergic cells.","method":"Immunohistochemistry of consecutive sections; radioimmunoassay; in situ hybridization","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-localization by IHC and RIA; directly establishes cell-type-specific localization","pmids":["10218899"],"is_preprint":false},{"year":2002,"finding":"The Oed-Sml ENU point mutation (V159E in Gnas exon 6) causes opposite parent-of-origin phenotypes: maternally transmitted mutation (via Gnas/Gsα) causes microcardia with gross edema, while paternally transmitted mutation (via Gnasxl) causes postnatal growth retardation, revealing distinct roles for Gsα in cardiac growth and XLαs in postnatal body growth.","method":"ENU mutagenesis; genetic mapping; sequencing of point mutation; uniparental transmission phenotyping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — point mutation with allele-specific phenotypes provides genetic evidence for distinct functions of each isoform; single lab","pmids":["12376090"],"is_preprint":false},{"year":2019,"finding":"GNAS knockdown in INS-1 β-cells reduces insulin secretion, insulin content, and cAMP production; expression of Insulin, PDX1, and MAFA is significantly downregulated, demonstrating that Gsα/cAMP signaling is required for normal β-cell insulin secretory capacity.","method":"siRNA knockdown in INS-1 cells; insulin secretion assay; cAMP measurement; RT-PCR for β-cell transcription factors","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct loss-of-function with multiple functional readouts in a relevant cell model; single lab","pmids":["31374326"],"is_preprint":false}],"current_model":"GNAS is a complex imprinted locus encoding multiple gene products from alternative first exons: Gsα (biallelically expressed in most tissues, maternally predominant in renal proximal tubules/thyroid/pituitary), XLαs (paternally expressed), and NESP55 (maternally expressed, a chromogranin-like protein in neuroendocrine secretory granules); Gsα couples GPCRs to adenylyl cyclase via a GTPase cycle (activating mutations at R201/Q227 impair GTP hydrolysis causing constitutive cAMP elevation), while XLαs and Gsα exert antagonistic effects on energy metabolism, and imprinting of the locus is controlled hierarchically by the Nespas DMR (principal ICR) and the NESP55 DMR, with the antisense Nespas lncRNA silencing Nesp via histone demethylation and subsequent DNA methylation in cis."},"narrative":{"mechanistic_narrative":"GNAS is a complex imprinted locus that produces multiple, oppositely imprinted gene products from alternative first exons within a single transcription unit, including the signaling protein Gsα, the paternally expressed XLαs, the maternally expressed neuroendocrine protein NESP55, and the paternally expressed antisense macroRNA Nespas [PMID:10097123]. Gsα couples seven-transmembrane receptors to adenylyl cyclase to generate cAMP through a GTPase cycle; somatic activating mutations at R201 and Q227 impair GTP hydrolysis to cause constitutive cAMP elevation in fibrous dysplasia, McCune-Albright syndrome, and endocrine tumors, while inactivating mutations produce Albright hereditary osteodystrophy with hormone resistance restricted to maternal inheritance owing to tissue-specific maternal-predominant Gsα expression [PMID:15331575]. Beyond canonical cAMP output, oncogenic Gsα signaling engages Wnt/β-catenin (via Lrp6) in fibrous dysplasia and colorectal cancer, modulates BMP-Smad-dependent osteoblast versus adipocyte fate, and a splicing-driven long isoform (Gsα-L) additionally activates ERK/MAPK signaling [PMID:29158412, PMID:22903279, PMID:34620690, PMID:35879396]. Gsα-dependent cAMP is required for β-cell insulin secretion and for melanocortin-4 receptor signaling, and receptor-selective signaling defects underlie GNAS-associated obesity [PMID:34614324, PMID:31374326]. The locus also exerts antagonistic metabolic control: Gsα and the paternal XLαs product have opposite effects on energy and glucose homeostasis [PMID:15883378, PMID:23822972]. NESP55 is a chromogranin-like acidic protein of neuroendocrine dense-core secretory granules, processed to bioactive peptides and functionally linked to noradrenergic and serotonergic neuronal systems and behavior [PMID:9111083, PMID:15798190]. Imprinting across the cluster is governed hierarchically by germline differentially methylated regions—the Nespas/Nesp DMRs act as principal imprinting control regions, with the antisense Nespas transcript silencing Nesp in cis through histone modification that can precede and is separable from DNA methylation [PMID:16462745, PMID:20427744, PMID:21455290].","teleology":[{"year":1997,"claim":"Established that the GNAS locus encodes more than Gsα by characterizing NESP55 as a neuroendocrine secretory protein, expanding the locus beyond a single signaling product.","evidence":"Molecular cloning, immunoblot, and gel electrophoresis of chromaffin granule secretory proteins","pmids":["9111083"],"confidence":"High","gaps":["Physiological role of NESP55-derived peptides in vivo not established","Relationship to Gsα-encoding transcripts not yet defined at this stage"]},{"year":1999,"claim":"Revealed that the locus is a single transcription unit producing oppositely imprinted transcripts, defining GNAS as a reciprocally imprinted cluster rather than a simple gene.","evidence":"Representational difference analysis, RT-PCR, and Northern blot in interspecific mouse crosses; plus cell-type-specific NESP55 localization in adrenergic chromaffin cells","pmids":["10097123","10218899"],"confidence":"High","gaps":["Mechanism enforcing parent-of-origin methylation not addressed","Functional consequences of each isoform not yet tested"]},{"year":2000,"claim":"Identified the paternal antisense Nespas transcript and allele-specific epigenetic features, pointing to a cis-regulatory architecture controlling imprinting.","evidence":"Strand-specific RT-PCR and Northern blot in uniparental disomy embryos; tissue-specific NESP55 splicing and PTM analysis","pmids":["10716699","10729789"],"confidence":"High","gaps":["Causal role of Nespas in silencing not yet demonstrated by perturbation","Hierarchy among DMRs unknown"]},{"year":2003,"claim":"Mapped allele-specific methylation and DNase I hypersensitivity to germline marks over Nespas/Gnasxl, separating their control from the Gnas promoter.","evidence":"Bisulfite sequencing and DNase I hypersensitivity across gametes, ES cells, and tissues","pmids":["12897124"],"confidence":"High","gaps":["Which DMR is the principal control region not resolved","Mechanism linking methylation to expression switching not shown"]},{"year":2004,"claim":"Defined the enzymatic basis of disease by showing R201/Q227 mutations impair GTPase turn-off to cause constitutive cAMP, unifying activating and inactivating phenotypes with imprinting.","evidence":"Biochemical GTPase assays, genetic analysis, and mouse knockout models","pmids":["15331575"],"confidence":"High","gaps":["Tissue-specific effectors downstream of cAMP not enumerated","Non-cAMP effector branches not yet identified"]},{"year":2005,"claim":"Demonstrated that Gsα and XLαs exert opposite effects on energy and glucose metabolism, dissociating metabolic phenotypes from a single gene product.","evidence":"Allele-specific Gnas exon deletions in mice with metabolic phenotyping; Nesp55 knockout with behavioral assays","pmids":["15883378","15798190"],"confidence":"High","gaps":["Molecular basis of XLαs antagonism of Gsα not defined","Neural circuit mediating Nesp55 behavioral phenotype unresolved"]},{"year":2006,"claim":"Identified the Nespas DMR as the principal bidirectional imprinting control region governing the entire cluster, establishing locus-wide hierarchical control.","evidence":"Paternal targeted DMR deletion in mice with allele-specific expression and methylation analysis","pmids":["16462745"],"confidence":"High","gaps":["Molecular mechanism of bidirectional switching not detailed","Role of antisense transcription versus the DNA element itself not separated"]},{"year":2010,"claim":"Established a second principal ICR (Nesp55 DMR) directing maternal Gnas methylation and downstream calcium/phosphate homeostasis, refining the imprinting hierarchy.","evidence":"Maternal-allele deletion mouse model with methylation, RT-PCR, and serum biochemistry","pmids":["20427744"],"confidence":"High","gaps":["Interaction between the two principal ICRs not mapped","Human relevance of mouse DMR hierarchy not directly tested here"]},{"year":2011,"claim":"Separated chromatin-based silencing from DNA methylation by showing Nespas silences Nesp via histone modification independent of and preceding DNA methylation.","evidence":"Nespas hypomorph knock-in with ChIP for histone marks, bisulfite analysis, and allele-specific RT-PCR","pmids":["21455290"],"confidence":"High","gaps":["Histone-modifying machinery recruited by Nespas not identified","Order of events in human cells not established"]},{"year":2012,"claim":"Linked cAMP level to cell-fate decisions by showing elevated cAMP inhibits osteoblast differentiation and enhances adipogenesis via BMP-Smad blockade, connecting GNAS signaling to bone disease mechanism.","evidence":"Pluripotent mouse ES cell osteogenic differentiation with pharmacological cAMP modulation and BMP-Smad readouts","pmids":["22903279"],"confidence":"Medium","gaps":["In vitro pharmacological model; in vivo relevance to fibrous dysplasia not tested here","Single lab"]},{"year":2013,"claim":"Used gene-dosage genetics to formally demonstrate antagonistic Gsα/XLαs actions across tissues, separating edema from the full lethal phenotype.","evidence":"Targeted mutations combined with uniparental disomy and metabolic/behavioral phenotyping","pmids":["23822972"],"confidence":"High","gaps":["Tissue-specific molecular targets of XLαs not identified","Mechanism of dose-dependent phenotype combination unresolved"]},{"year":2015,"claim":"Showed that Nespas transcription is necessary and sufficient for Nesp DMR methylation and that transcription can drive somatic de novo CpG methylation, defining a transcription-coupled methylation mechanism.","evidence":"Truncating and ectopic-transcription knock-in mouse alleles with bisulfite and allele-specific RT-PCR","pmids":["29861426","25659103"],"confidence":"Medium","gaps":["Methyltransferase complex coupling transcription to methylation not identified","Single-lab genetic models"]},{"year":2017,"claim":"Demonstrated in vivo that activating GNAS R201H drives fibrous dysplasia through Wnt/β-catenin via Lrp6, providing a genetically validated effector branch and rescue target.","evidence":"Conditional knock-in mouse with histology, Western blot, and Lrp6 heterozygosity rescue","pmids":["29158412"],"confidence":"High","gaps":["Direct molecular link from cAMP/PKA to Wnt activation not fully defined","Generality across other GNAS-driven tissues not tested here"]},{"year":2019,"claim":"Expanded GNAS signaling to context-specific tumor behavior and β-cell function, showing PKA-dependent NOTCH regulation in pancreatic cancer and cAMP-dependent insulin secretion.","evidence":"CRISPR R201H manipulation with xenografts and NICD analysis; siRNA knockdown in INS-1 β-cells with secretion and transcription factor readouts","pmids":["35018527","31374326"],"confidence":"Medium","gaps":["Single-lab models for each context","Direct PKA-NOTCH and PKA-β-cell transcription factor links not biochemically reconstituted"]},{"year":2021,"claim":"Explained clinical heterogeneity of GNAS-associated obesity by showing mutations differentially impair MC4R, GHRHR, and TSHR signaling, linking receptor-selective cAMP defects to phenotype.","evidence":"Exome sequencing with receptor-specific cAMP signaling assays and genotype-phenotype correlation in a patient cohort","pmids":["34614324"],"confidence":"High","gaps":["Structural basis for receptor-selective coupling defects not resolved","Tissue-level integration of multiple receptor defects not modeled"]},{"year":2022,"claim":"Revealed non-cAMP and isoform-specific oncogenic mechanisms: splicing-driven Gsα-L activates ERK/MAPK, and R201 mutations drive β-catenin in colorectal cancer with oncogene addiction.","evidence":"RNA-seq/eCLIP in isogenic iPSC-derived HSPCs with biochemical assays and MEK inhibitor sensitivity; CRISPR GNAS knockout in CRC with organoid/xenograft and PKA/β-catenin inhibition","pmids":["34620690","35879396"],"confidence":"High","gaps":["Switch determining cAMP versus ERK output not defined","Relative contribution of Wnt versus PKA in CRC growth not separated"]},{"year":2023,"claim":"Defined human imprinting architecture by showing the NESP-ICR controls A/B silencing and the STX16-ICR acts as a pluripotency-factor-dependent long-range enhancer of NESP55, and identified GPR176 as an intracellular Gsα-recruiting receptor controlling mitophagy.","evidence":"CRISPR ICR deletions in hESCs with allele-specific methylation/expression and ChIP; Co-IP and domain modeling with cAMP/mitophagy assays and CRC mouse models","pmids":["36853809","36905238"],"confidence":"High","gaps":["Conservation of STX16-ICR enhancer mechanism in non-embryonic tissues unclear","GPR176/GNAS interaction validated by single-lab Co-IP and modeling"]},{"year":2024,"claim":"Connected GNAS protein stability to chemoresistance by showing a PRKDC-GDE2 axis stabilizes GNAS to drive AKT activation and doxorubicin resistance in osteosarcoma.","evidence":"CRISPR kinome screen, Co-IP of PRKDC/GDE2/GNAS, stability assays, xenografts, and organoids","pmids":["38900943"],"confidence":"Medium","gaps":["Mechanism by which PRKDC/GDE2 stabilizes GNAS not defined","Single lab; interaction not reciprocally validated across systems"]},{"year":null,"claim":"How Gsα output is partitioned between cAMP/PKA, Wnt/β-catenin, and ERK/MAPK branches across tissues, and how the imprinting hierarchy and isoform antagonism are integrated into human disease, remains incompletely resolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking receptor identity to effector branch selection","Molecular machinery coupling Nespas transcription to methylation not identified","Mechanistic basis of Gsα/XLαs metabolic antagonism unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[6,17,20]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[6]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[11,12,13]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,20]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,20]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1,26]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,17,18,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,11,19]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5,11]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,15,17,22]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,14,28]}],"complexes":[],"partners":["GPR176","LRP6","PRKDC","GDE2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P84996","full_name":"Protein ALEX","aliases":["Alternative gene product encoded by XL-exon"],"length_aa":626,"mass_kda":67.9,"function":"May inhibit the adenylyl cyclase-stimulating activity of guanine nucleotide-binding protein G(s) subunit alpha which is produced from the same locus in a different open reading frame","subcellular_location":"Cell membrane; Cell projection, ruffle","url":"https://www.uniprot.org/uniprotkb/P84996/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAS","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"GNB1","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/search/GNAS","total_profiled":1310},"omim":[{"mim_id":"617686","title":"PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3","url":"https://www.omim.org/entry/617686"},{"mim_id":"617630","title":"G PROTEIN-COUPLED RECEPTOR 37-LIKE 1; GPR37L1","url":"https://www.omim.org/entry/617630"},{"mim_id":"617352","title":"MULCHANDANI-BHOJ-CONLIN SYNDROME; MBCS","url":"https://www.omim.org/entry/617352"},{"mim_id":"615650","title":"REGULATOR OF G PROTEIN SIGNALING 22; RGS22","url":"https://www.omim.org/entry/615650"},{"mim_id":"613639","title":"ADHESION G PROTEIN-COUPLED RECEPTOR D1; ADGRD1","url":"https://www.omim.org/entry/613639"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"},{"location":"Plasma membrane","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GNAS"},"hgnc":{"alias_symbol":["NESP55","NESP","GNASXL","GPSA","SCG6","SgVI"],"prev_symbol":["GNAS1"]},"alphafold":{"accession":"P84996","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P84996","model_url":"https://alphafold.ebi.ac.uk/files/AF-P84996-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P84996-F1-predicted_aligned_error_v6.png","plddt_mean":43.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAS","jax_strain_url":"https://www.jax.org/strain/search?query=GNAS"},"sequence":{"accession":"P84996","fasta_url":"https://rest.uniprot.org/uniprotkb/P84996.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P84996/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P84996"}},"corpus_meta":[{"pmid":"11308268","id":"PMC_11308268","title":"Development and characterization of novel erythropoiesis stimulating protein (NESP).","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11308268","citation_count":401,"is_preprint":false},{"pmid":"15331575","id":"PMC_15331575","title":"Minireview: GNAS: normal and abnormal functions.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15331575","citation_count":242,"is_preprint":false},{"pmid":"10097123","id":"PMC_10097123","title":"A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10097123","citation_count":215,"is_preprint":false},{"pmid":"11402085","id":"PMC_11402085","title":"Development and characterization of novel erythropoiesis stimulating protein (NESP).","date":"2001","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/11402085","citation_count":190,"is_preprint":false},{"pmid":"9111083","id":"PMC_9111083","title":"Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9111083","citation_count":172,"is_preprint":false},{"pmid":"24938521","id":"PMC_24938521","title":"Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.","date":"2014","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/24938521","citation_count":164,"is_preprint":false},{"pmid":"16462745","id":"PMC_16462745","title":"Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster.","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16462745","citation_count":163,"is_preprint":false},{"pmid":"15883378","id":"PMC_15883378","title":"Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15883378","citation_count":151,"is_preprint":false},{"pmid":"25851935","id":"PMC_25851935","title":"GNAS Spectrum of Disorders.","date":"2015","source":"Current osteoporosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/25851935","citation_count":138,"is_preprint":false},{"pmid":"15711092","id":"PMC_15711092","title":"GNAS locus and pseudohypoparathyroidism.","date":"2005","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/15711092","citation_count":132,"is_preprint":false},{"pmid":"10716699","id":"PMC_10716699","title":"An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10716699","citation_count":131,"is_preprint":false},{"pmid":"19065104","id":"PMC_19065104","title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.","date":"2009","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19065104","citation_count":125,"is_preprint":false},{"pmid":"16286456","id":"PMC_16286456","title":"Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16286456","citation_count":111,"is_preprint":false},{"pmid":"23335286","id":"PMC_23335286","title":"KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.","date":"2013","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23335286","citation_count":103,"is_preprint":false},{"pmid":"15798190","id":"PMC_15798190","title":"Imprinted Nesp55 influences behavioral reactivity to novel environments.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15798190","citation_count":100,"is_preprint":false},{"pmid":"12897124","id":"PMC_12897124","title":"Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12897124","citation_count":95,"is_preprint":false},{"pmid":"25219572","id":"PMC_25219572","title":"GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.","date":"2014","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/25219572","citation_count":94,"is_preprint":false},{"pmid":"18252944","id":"PMC_18252944","title":"Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse.","date":"2008","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18252944","citation_count":90,"is_preprint":false},{"pmid":"12460230","id":"PMC_12460230","title":"The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.","date":"2002","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/12460230","citation_count":88,"is_preprint":false},{"pmid":"27512631","id":"PMC_27512631","title":"KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.","date":"2016","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/27512631","citation_count":83,"is_preprint":false},{"pmid":"11402086","id":"PMC_11402086","title":"An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP).","date":"2001","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/11402086","citation_count":76,"is_preprint":false},{"pmid":"18372789","id":"PMC_18372789","title":"The GNAS locus and pseudohypoparathyroidism.","date":"2008","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/18372789","citation_count":76,"is_preprint":false},{"pmid":"21455290","id":"PMC_21455290","title":"Uncoupling antisense-mediated silencing and DNA methylation in the imprinted Gnas cluster.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21455290","citation_count":76,"is_preprint":false},{"pmid":"22378814","id":"PMC_22378814","title":"A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib.","date":"2012","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22378814","citation_count":75,"is_preprint":false},{"pmid":"31267263","id":"PMC_31267263","title":"GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization.","date":"2019","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31267263","citation_count":75,"is_preprint":false},{"pmid":"34614324","id":"PMC_34614324","title":"Obesity-Associated GNAS Mutations and the Melanocortin Pathway.","date":"2021","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34614324","citation_count":70,"is_preprint":false},{"pmid":"19844212","id":"PMC_19844212","title":"The role of GNAS and other imprinted genes in the development of obesity.","date":"2009","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/19844212","citation_count":70,"is_preprint":false},{"pmid":"32123532","id":"PMC_32123532","title":"GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.","date":"2020","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32123532","citation_count":70,"is_preprint":false},{"pmid":"17588669","id":"PMC_17588669","title":"Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.","date":"2007","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17588669","citation_count":65,"is_preprint":false},{"pmid":"24107509","id":"PMC_24107509","title":"The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene.","date":"2013","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/24107509","citation_count":62,"is_preprint":false},{"pmid":"15915160","id":"PMC_15915160","title":"Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with severe pre- and post-natal growth retardation and intractable feeding difficulties.","date":"2005","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15915160","citation_count":62,"is_preprint":false},{"pmid":"11056047","id":"PMC_11056047","title":"Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11056047","citation_count":60,"is_preprint":false},{"pmid":"11308271","id":"PMC_11308271","title":"Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11308271","citation_count":59,"is_preprint":false},{"pmid":"20841428","id":"PMC_20841428","title":"Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells.","date":"2010","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20841428","citation_count":58,"is_preprint":false},{"pmid":"30767161","id":"PMC_30767161","title":"Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.","date":"2019","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/30767161","citation_count":58,"is_preprint":false},{"pmid":"29158412","id":"PMC_29158412","title":"Induced Gnas expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29158412","citation_count":58,"is_preprint":false},{"pmid":"11308269","id":"PMC_11308269","title":"Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11308269","citation_count":55,"is_preprint":false},{"pmid":"25867268","id":"PMC_25867268","title":"Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.","date":"2015","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25867268","citation_count":55,"is_preprint":false},{"pmid":"36905238","id":"PMC_36905238","title":"GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36905238","citation_count":54,"is_preprint":false},{"pmid":"20803660","id":"PMC_20803660","title":"Imprinting on chromosome 20: tissue-specific imprinting and imprinting mutations in the GNAS locus.","date":"2010","source":"American journal of medical genetics. Part C, Seminars in medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20803660","citation_count":53,"is_preprint":false},{"pmid":"11308270","id":"PMC_11308270","title":"A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11308270","citation_count":52,"is_preprint":false},{"pmid":"20427744","id":"PMC_20427744","title":"Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20427744","citation_count":50,"is_preprint":false},{"pmid":"34620690","id":"PMC_34620690","title":"Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor-Mutant Neoplasms.","date":"2022","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34620690","citation_count":50,"is_preprint":false},{"pmid":"19412439","id":"PMC_19412439","title":"The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted Transcripts.","date":"2007","source":"Current genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19412439","citation_count":48,"is_preprint":false},{"pmid":"22903279","id":"PMC_22903279","title":"Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.","date":"2012","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/22903279","citation_count":48,"is_preprint":false},{"pmid":"9426138","id":"PMC_9426138","title":"Expression of gpsA encoding biosynthetic sn-glycerol 3-phosphate dehydrogenase suppresses both the LB- phenotype of a secB null mutant and the cold-sensitive phenotype of a secG null mutant.","date":"1997","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9426138","citation_count":47,"is_preprint":false},{"pmid":"26333472","id":"PMC_26333472","title":"DNA methylation in imprinted genes IGF2 and GNASXL is associated with prenatal maternal stress.","date":"2015","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/26333472","citation_count":46,"is_preprint":false},{"pmid":"12376090","id":"PMC_12376090","title":"The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for Gnas and Gnasxl in development.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12376090","citation_count":43,"is_preprint":false},{"pmid":"30204251","id":"PMC_30204251","title":"GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.","date":"2018","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30204251","citation_count":43,"is_preprint":false},{"pmid":"28776576","id":"PMC_28776576","title":"GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.","date":"2017","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/28776576","citation_count":43,"is_preprint":false},{"pmid":"18094621","id":"PMC_18094621","title":"Control of imprinting at the Gnas cluster.","date":"2007","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18094621","citation_count":39,"is_preprint":false},{"pmid":"31297884","id":"PMC_31297884","title":"hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31297884","citation_count":38,"is_preprint":false},{"pmid":"23548772","id":"PMC_23548772","title":"GNAS -Related Loss-of-Function Disorders and the Role of Imprinting.","date":"2013","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/23548772","citation_count":37,"is_preprint":false},{"pmid":"26248895","id":"PMC_26248895","title":"GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.","date":"2015","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/26248895","citation_count":36,"is_preprint":false},{"pmid":"30376114","id":"PMC_30376114","title":"Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30376114","citation_count":34,"is_preprint":false},{"pmid":"10350534","id":"PMC_10350534","title":"Relative amounts and molecular forms of NESP55 in various bovine tissues.","date":"1999","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10350534","citation_count":33,"is_preprint":false},{"pmid":"28483487","id":"PMC_28483487","title":"Mechanical stress affects methylation pattern of GNAS isoforms and osteogenic differentiation of hAT-MSCs.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28483487","citation_count":33,"is_preprint":false},{"pmid":"28889026","id":"PMC_28889026","title":"GNAS mutations and heterotopic ossification.","date":"2017","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/28889026","citation_count":32,"is_preprint":false},{"pmid":"10729789","id":"PMC_10729789","title":"Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein.","date":"2000","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10729789","citation_count":31,"is_preprint":false},{"pmid":"15371954","id":"PMC_15371954","title":"Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids.","date":"2004","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15371954","citation_count":31,"is_preprint":false},{"pmid":"12771991","id":"PMC_12771991","title":"NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.","date":"2003","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12771991","citation_count":31,"is_preprint":false},{"pmid":"20398730","id":"PMC_20398730","title":"GNAS imprinting and pituitary tumors.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20398730","citation_count":30,"is_preprint":false},{"pmid":"11889554","id":"PMC_11889554","title":"Alternative non-coding splice variants of Nespas, an imprinted gene antisense to Nesp in the Gnas imprinting cluster.","date":"2002","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11889554","citation_count":30,"is_preprint":false},{"pmid":"33082481","id":"PMC_33082481","title":"GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33082481","citation_count":30,"is_preprint":false},{"pmid":"15759304","id":"PMC_15759304","title":"Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP).","date":"2005","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/15759304","citation_count":30,"is_preprint":false},{"pmid":"22674477","id":"PMC_22674477","title":"GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?","date":"2012","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/22674477","citation_count":29,"is_preprint":false},{"pmid":"16575178","id":"PMC_16575178","title":"Imprinting the Gnas locus.","date":"2006","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16575178","citation_count":29,"is_preprint":false},{"pmid":"38900943","id":"PMC_38900943","title":"PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38900943","citation_count":28,"is_preprint":false},{"pmid":"27864998","id":"PMC_27864998","title":"RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct.","date":"2017","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/27864998","citation_count":28,"is_preprint":false},{"pmid":"24525511","id":"PMC_24525511","title":"Activating GNAS mutations in parosteal osteosarcoma.","date":"2014","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24525511","citation_count":27,"is_preprint":false},{"pmid":"10218899","id":"PMC_10218899","title":"The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla.","date":"1999","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10218899","citation_count":25,"is_preprint":false},{"pmid":"16789629","id":"PMC_16789629","title":"Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism.","date":"2006","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/16789629","citation_count":25,"is_preprint":false},{"pmid":"26743443","id":"PMC_26743443","title":"GNAS mutations in adrenal aldosterone-producing adenomas.","date":"2016","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/26743443","citation_count":24,"is_preprint":false},{"pmid":"30879148","id":"PMC_30879148","title":"Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.","date":"2019","source":"Surgery today","url":"https://pubmed.ncbi.nlm.nih.gov/30879148","citation_count":24,"is_preprint":false},{"pmid":"34711663","id":"PMC_34711663","title":"Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34711663","citation_count":24,"is_preprint":false},{"pmid":"32700107","id":"PMC_32700107","title":"The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.","date":"2020","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32700107","citation_count":23,"is_preprint":false},{"pmid":"21214909","id":"PMC_21214909","title":"DNA sequence polymorphisms within the bovine guanine nucleotide-binding protein Gs subunit alpha (Gsα)-encoding (GNAS) genomic imprinting domain are associated with performance traits.","date":"2011","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21214909","citation_count":23,"is_preprint":false},{"pmid":"18372788","id":"PMC_18372788","title":"Control of imprinting at the Gnas cluster.","date":"2008","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/18372788","citation_count":22,"is_preprint":false},{"pmid":"35018527","id":"PMC_35018527","title":"Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.","date":"2022","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/35018527","citation_count":22,"is_preprint":false},{"pmid":"35879396","id":"PMC_35879396","title":"Oncogene addiction to GNAS in GNASR201 mutant tumors.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35879396","citation_count":21,"is_preprint":false},{"pmid":"25435574","id":"PMC_25435574","title":"Differential expression of GNAS and KRAS mutations in pancreatic cysts.","date":"2014","source":"JOP : Journal of the pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/25435574","citation_count":21,"is_preprint":false},{"pmid":"31374326","id":"PMC_31374326","title":"GNAS gene is an important regulator of insulin secretory capacity in pancreatic β-cells.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31374326","citation_count":21,"is_preprint":false},{"pmid":"35255112","id":"PMC_35255112","title":"The glycerol-3-phosphate dehydrogenases GpsA and GlpD constitute the oxidoreductive metabolic linchpin for Lyme disease spirochete host infectivity and persistence in the tick.","date":"2022","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/35255112","citation_count":20,"is_preprint":false},{"pmid":"36853809","id":"PMC_36853809","title":"The long-range interaction between two GNAS imprinting control regions delineates pseudohypoparathyroidism type 1B pathogenesis.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36853809","citation_count":20,"is_preprint":false},{"pmid":"27509352","id":"PMC_27509352","title":"Impulsive choices in mice lacking imprinted Nesp55.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/27509352","citation_count":20,"is_preprint":false},{"pmid":"15457345","id":"PMC_15457345","title":"Imprinting of Nesp55 gene in cattle.","date":"2004","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/15457345","citation_count":20,"is_preprint":false},{"pmid":"33914475","id":"PMC_33914475","title":"Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.","date":"2023","source":"Annals of surgery","url":"https://pubmed.ncbi.nlm.nih.gov/33914475","citation_count":19,"is_preprint":false},{"pmid":"25659103","id":"PMC_25659103","title":"Transcription driven somatic DNA methylation within the imprinted Gnas cluster.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25659103","citation_count":18,"is_preprint":false},{"pmid":"36428574","id":"PMC_36428574","title":"A GNAS Gene Mutation's Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36428574","citation_count":18,"is_preprint":false},{"pmid":"36593655","id":"PMC_36593655","title":"Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.","date":"2023","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/36593655","citation_count":18,"is_preprint":false},{"pmid":"25005734","id":"PMC_25005734","title":"Very small deletions within the NESP55 gene in pseudohypoparathyroidism type 1b.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25005734","citation_count":18,"is_preprint":false},{"pmid":"334747","id":"PMC_334747","title":"Further mapping of several membrane lipid biosynthetic genes (fabC, fabB, gpsA, plsB) of Escherichia coli.","date":"1977","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/334747","citation_count":17,"is_preprint":false},{"pmid":"23974804","id":"PMC_23974804","title":"Brain-expressed imprinted genes and adult behaviour: the example of Nesp and Grb10.","date":"2013","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/23974804","citation_count":16,"is_preprint":false},{"pmid":"39340996","id":"PMC_39340996","title":"Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39340996","citation_count":15,"is_preprint":false},{"pmid":"23822972","id":"PMC_23822972","title":"Gene Dosage Effects at the Imprinted Gnas Cluster.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23822972","citation_count":14,"is_preprint":false},{"pmid":"27186325","id":"PMC_27186325","title":"GNAS gene mutation may be present only transiently during colorectal tumorigenesis.","date":"2016","source":"International journal of molecular epidemiology and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27186325","citation_count":14,"is_preprint":false},{"pmid":"29861426","id":"PMC_29861426","title":"Antisense Activity across the Nesp Promoter is Required for Nespas-Mediated Silencing in the Imprinted Gnas Cluster.","date":"2015","source":"Non-coding RNA","url":"https://pubmed.ncbi.nlm.nih.gov/29861426","citation_count":14,"is_preprint":false},{"pmid":"11934480","id":"PMC_11934480","title":"Distribution and intraneuronal trafficking of a novel member of the chromogranin family, NESP55, in the rat peripheral nervous system.","date":"2002","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11934480","citation_count":14,"is_preprint":false},{"pmid":"35012940","id":"PMC_35012940","title":"Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.","date":"2022","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/35012940","citation_count":14,"is_preprint":false},{"pmid":"32271425","id":"PMC_32271425","title":"Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32271425","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54178,"output_tokens":7124,"usd":0.134697,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16495,"output_tokens":5614,"usd":0.111412,"stage2_stop_reason":"end_turn"},"total_usd":0.246109,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"The Gnas locus encodes multiple oppositely imprinted transcripts (Gnasxl, Nesp/NESP55, and Gnas) within a single transcription unit; Gnasxl and Nesp transcripts are alternatively spliced onto exon 2 of Gnas. Gnasxl is maternally methylated and paternally expressed, whereas Nesp is paternally methylated and maternally expressed.\",\n      \"method\": \"Representational difference analysis based on parent-of-origin methylation differences; RT-PCR and Northern blot in interspecific mouse crosses\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal imprinting confirmed by multiple orthogonal methods (RDA, RT-PCR, Northern blot) and replicated across subsequent studies\",\n      \"pmids\": [\"10097123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NESP55 (encoded by the GNAS locus, maternally expressed) is a chromogranin-like acidic protein localized to large dense-core secretory vesicles in neuroendocrine tissues; it is proteolytically processed within chromaffin granules to smaller peptides, including the tetrapeptide LSAL (flanked by prohormone convertase cleavage sites), which acts as an endogenous 5-HT1B receptor antagonist.\",\n      \"method\": \"Molecular cloning; immunoblot; immunofluorescence; 1D/2D gel electrophoresis of secretory proteins from chromaffin granules\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct biochemical characterization with multiple orthogonal methods; replicated in subsequent studies confirming secretory granule localization\",\n      \"pmids\": [\"9111083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A paternal-allele-specific antisense transcript (Nespas/Gnas-as) originates ~2.2 kb upstream of the Gnasxl promoter and spans the Nesp region; it is expressed exclusively from the paternal allele in most tissues, suggesting a cis-regulatory role in imprinting of the Nesp sense transcript.\",\n      \"method\": \"Strand-specific RT-PCR; Northern blot analysis in embryos carrying uniparental disomy for distal Chr 2\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — parental allele specificity confirmed by uniparental disomy embryos with strand-specific RT-PCR; independently replicated\",\n      \"pmids\": [\"10716699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NESP55 mRNA is alternatively spliced in a tissue-specific manner onto Gsα exons 2–13 (adrenal, pituitary, brain) or onto exons 2, 3, N1 (pituitary); the protein is posttranslationally modified by keratan sulfate glycosaminoglycan addition and differentially processed by endopeptidases in various tissues.\",\n      \"method\": \"cDNA cloning, RT-PCR, Northern blot, protein sequencing\",\n      \"journal\": \"Neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in a single lab confirming splice variants and PTM\",\n      \"pmids\": [\"10729789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NESP55 undergoes fast anterograde axonal transport in peripheral neurons and is slowly proteolytically processed to smaller peptides (including GAIPIRRH) during transport; it is not retrogradely transported and is absent from terminal regions.\",\n      \"method\": \"Crush-operated sciatic nerve experiments; immunohistochemistry; HPLC-radioimmunoassay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo localization with nerve crush and biochemical analysis; single lab, two orthogonal methods\",\n      \"pmids\": [\"11934480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Nesp and Gnasxl promoter regions are embedded in extensive CpG islands with allele-specific methylation (paternal methylation at Nesp; maternal methylation at Gnasxl). Parental allele-specific DNase I-hypersensitive sites correlate with the hypomethylated (active) allele. A germline methylation mark covering Gnasxl and Nespas promoters was identified, suggesting separate control from the Gnas promoter.\",\n      \"method\": \"Bisulfite sequencing; DNase I hypersensitivity assay in gametes, ES cells, and tissues\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal epigenetic methods (bisulfite sequencing + DNase I) across developmental stages; replicated by subsequent studies\",\n      \"pmids\": [\"12897124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Gsα (encoded by GNAS) couples seven-transmembrane receptors to adenylyl cyclase to generate cAMP. Somatic activating mutations at residues R201 and Q227 (which impair the GTPase turn-off reaction) cause constitutive adenylyl cyclase activation, found in endocrine tumors, fibrous dysplasia, and McCune-Albright syndrome. Heterozygous inactivating mutations cause Albright hereditary osteodystrophy, with hormone resistance only on maternal inheritance due to tissue-specific maternal-allele-predominant expression.\",\n      \"method\": \"Biochemical characterization of GTPase activity; genetic analysis; mouse knockout models\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — enzymatic mechanism (GTPase impairment) established by in vitro assays; replicated across many labs and confirmed in multiple disease models\",\n      \"pmids\": [\"15331575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Gsα deficiency from maternal allele (via exon 1 deletion) causes obesity and insulin resistance, phenotypically distinct from paternal exon 2 deletion. The lean, hypermetabolic, insulin-sensitive phenotype of paternal exon 2 deletion mice results from XLαs (Gnasxl product) deficiency, not Gsα loss. Thus, Gsα and XLαs have opposite effects on energy/glucose metabolism.\",\n      \"method\": \"Targeted gene deletion of Gnas exon 1 in mice; metabolic phenotyping; comparison with exon 2 mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using multiple allele-specific knockouts; phenotypic readouts (body weight, insulin sensitivity, metabolic rate) in vivo\",\n      \"pmids\": [\"15883378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Knockout of Nesp55 in mice produces no metabolic or developmental defect but causes abnormal reactivity to novel environments (hyperreactivity in three behavioral tasks) independent of general locomotion and anxiety, associated with prominent Nesp55 expression in the noradrenergic locus coeruleus.\",\n      \"method\": \"Gene targeting knockout; behavioral assays (open field, elevated plus maze, light-dark box)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with specific behavioral phenotypes; replicated in follow-up behavioral studies\",\n      \"pmids\": [\"15798190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A paternally derived targeted deletion of the germline differentially methylated region (DMR) associated with the antisense Nespas transcript (Nespas DMR) unexpectedly abolishes expression of all transcripts in the Gnas cluster and methylation of two downstream DMRs, establishing the Nespas DMR as the principal imprinting control region (ICR) that acts bidirectionally to switch expression between Gnasxl and Gnas.\",\n      \"method\": \"Targeted deletion in mice; allele-specific RT-PCR; bisulfite methylation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo targeted deletion with allele-specific expression and methylation analysis; published in high-impact journal with rigorous controls\",\n      \"pmids\": [\"16462745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Targeted deletion of the region equivalent to the NESP55 DMR (delNesp55) on the maternal allele causes loss of all maternal Gnas methylation imprints; in kidney this leads to increased 1A transcription, decreased Gsα mRNA, and hypocalcemia/hyperphosphatemia/secondary hyperparathyroidism, establishing the Nesp55 DMR as an additional principal ICR directing Gnas methylation.\",\n      \"method\": \"Mouse knock-in/deletion model; bisulfite methylation analysis; quantitative RT-PCR; serum calcium/phosphate measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo allele-specific deletion with methylation, expression, and biochemical phenotype readouts in a single rigorous study\",\n      \"pmids\": [\"20427744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The paternally expressed macroRNA Nespas silences Nesp in cis via chromatin modification (reduced H3K4me3 demethylation and H3K36me3 depletion at the Nesp promoter), independent of DNA methylation, demonstrating that Nespas-mediated silencing can precede and is mechanistically separable from somatic DNA methylation.\",\n      \"method\": \"Nespas hypomorph knock-in allele; ChIP for histone modifications; bisulfite methylation analysis; allele-specific RT-PCR\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal chromatin and expression methods in a controlled knock-in model\",\n      \"pmids\": [\"21455290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nespas transcript/transcription across the ~2.6 kb region encompassing the Nesp promoter is necessary and sufficient for DNA methylation of the Nesp DMR; higher levels of Nespas are required for methylation than for transcriptional downregulation of Nesp. Nespas is strictly cis-acting even at supraphysiological levels.\",\n      \"method\": \"Knock-in alleles truncating Nespas upstream and downstream of Nesp promoter; bisulfite methylation; allele-specific RT-PCR\",\n      \"journal\": \"Non-coding RNA\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic dissection with two independent knock-in alleles; single lab\",\n      \"pmids\": [\"29861426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"On the paternal allele, ectopic transcription of Nesp traversing the intragenic Exon1A DMR causes somatic de novo methylation of that DMR and de-repression of Gnas, demonstrating that transcription-driven de novo CpG methylation of an intragenic island can occur in somatic (non-germline) tissues.\",\n      \"method\": \"Mutant mouse models with ectopic Nesp expression on paternal allele; bisulfite methylation; allele-specific RT-PCR; phenotypic analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic model with orthogonal methylation and expression assays; single lab\",\n      \"pmids\": [\"25659103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gene dosage analysis in PatDp(dist2) mice shows that oedema is caused by loss of imprinted Gnas expression alone, while the full hyperactive/chunky/lethal phenotype requires combination of double-dose Gnasxl and absent imprinted Gnas, demonstrating antagonistic actions of Gsα and XLαs in multiple tissues including glucose homeostasis.\",\n      \"method\": \"Targeted mutations combined with uniparental disomy; metabolic/behavioral phenotyping; glucose measurements\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dose manipulation with multiple allele combinations; multiple phenotypic readouts; replication of core Gsα/XLαs antagonism finding\",\n      \"pmids\": [\"23822972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Conditional knock-in of the activating GNAS R201H (fibrous dysplasia) mutation in osteochondral progenitors, osteoblasts, or bone marrow stromal cells (BMSCs) causes fibrous dysplasia features; the mechanism involves up-regulation of Wnt/β-catenin signaling, and removal of one Lrp6 copy significantly rescues the phenotype.\",\n      \"method\": \"Conditional knock-in mouse model; histology; Western blot; genetic rescue (Lrp6 heterozygosity)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knock-in with genetic epistasis rescue; multiple cell-type experiments\",\n      \"pmids\": [\"29158412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"At early stages of osteogenesis, increased cAMP signaling (mimicking activating GNAS mutation as in fibrous dysplasia) inhibits osteoblast differentiation and enhances adipogenesis partly by blocking BMP-Smad pathway signaling; inhibition of cAMP (as in inactivating GNAS mutations/POH) enhances osteoblast differentiation by stimulating BMP signaling.\",\n      \"method\": \"Pluripotent mouse ES cell osteogenic differentiation assay; pharmacological cAMP modulation (forskolin, 2',5'-dideoxyadenosine); BMP-Smad pathway readouts\",\n      \"journal\": \"Hormone and metabolic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro differentiation assay with pharmacological tools and pathway readout; single lab\",\n      \"pmids\": [\"22903279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GNAS mutations that cause obesity differentially impair MC4R (melanocortin 4 receptor) signaling, growth hormone-releasing hormone receptor signaling, and thyrotropin receptor signaling, explaining clinical heterogeneity; the obesity phenotype is mechanistically linked to defective MC4R/Gsα-mediated cAMP generation.\",\n      \"method\": \"Exome sequencing; functional GPCR signaling assays (cAMP production) for each mutation; clinical correlation with receptor-specific signaling\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro functional assays for multiple GPCR pathways with genotype-phenotype correlation in a large patient cohort\",\n      \"pmids\": [\"34614324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Splicing factor mutations (U2AF1 and SRSF2) in MDS promote a long isoform of GNAS (GNAS-L) that encodes a hyperactive Gαs-L protein. GNAS-L activates ERK/MAPK signaling (not only cAMP), and MDS cells with SF mutations are sensitive to MEK inhibitors.\",\n      \"method\": \"RNA-seq; eCLIP in isogenic iPSC-derived hematopoietic stem/progenitor cells; biochemical cAMP/ERK assays; MEK inhibitor sensitivity assays\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — convergent RNA-seq and eCLIP evidence plus functional biochemical assays and pharmacological sensitivity in isogenic models\",\n      \"pmids\": [\"34620690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The NESP55 imprinting control region (NESP-ICR) is required for DNA methylation and transcriptional silencing of the GNAS A/B region on the maternal allele; the STX16-ICR acts as a long-range enhancer of NESP55 transcription from the maternal allele, and this enhancer activity is enabled by direct binding of pluripotency factors in an embryonic stage-specific manner.\",\n      \"method\": \"CRISPR/Cas9 ICR deletions in human embryonic stem cells; allele-specific methylation and expression analysis; chromatin immunoprecipitation for pluripotency factor binding\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — CRISPR deletion in hESC model with allele-specific methylation, expression, and ChIP; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"36853809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GPR176 recruits GNAS intracellularly via its transmembrane helix 3-intracellular loop 2 domain; the GPR176/GNAS complex activates cAMP/PKA signaling and inhibits mitophagy through the cAMP/PKA/BNIP3L axis in colorectal cancer cells.\",\n      \"method\": \"Co-immunoprecipitation; homology modeling; cAMP measurements; mitophagy assays; genetic mouse models of CRC with Gpr176-deficiency\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP binding confirmed with domain modeling; functional pathway confirmed in vivo; single lab\",\n      \"pmids\": [\"36905238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nesp55 protein is co-localized with serotonin in midbrain neurons; mice lacking Nesp55 show impulsive choice behavior and reduced mRNA expression of serotonergic genes (Tph2, Slc6a4) in midbrain regions, implicating Nesp55 in regulation of the serotonin system and impulse control.\",\n      \"method\": \"Nesp55 knockout mouse (Nespm/+); delayed reinforcement task; stop-signal reaction time task; immunofluorescence co-localization; qPCR\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with specific behavioral assays and co-localization; single lab, two orthogonal methods\",\n      \"pmids\": [\"27509352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Oncogenic GNAS R201C/H mutations drive cAMP/PKA signaling and activate β-catenin phosphorylation and Wnt/β-catenin target genes in colorectal cancer cells; GNAS knockout reduces tumor growth in peritoneal models, and chemical inhibition of PKA or β-catenin reduces organoid growth, demonstrating oncogene addiction.\",\n      \"method\": \"CRISPR/Cas9 GNAS knockout in CRC cell lines; 2D/3D organoid growth assays; xenograft mouse models; cAMP measurements; molecular profiling (western blot, PKA/β-catenin inhibitors)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with in vivo xenograft and in vitro pharmacological pathway dissection; single lab\",\n      \"pmids\": [\"35879396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Mutant GNAS R201H in IPMN-associated pancreatic cancer cells promotes mucin production (MUC2, MUC5AC/B) and limits tumor aggressiveness by negatively regulating NOTCH signaling via the GNAS-PKA pathway; PKA inhibition induces NOTCH intracellular domain (NICD) in GNAS-mutant cells, while GNAS wild-type cells show higher NICD levels and invasive capacity.\",\n      \"method\": \"CRISPR/Cas9 GNAS R201H silencing; xenograft experiments; western blot; transcriptome analysis; nuclear fractionation for NICD; PKA inhibitor treatment\",\n      \"journal\": \"Journal of gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR manipulation in primary cells with xenograft and molecular pathway analysis; single lab\",\n      \"pmids\": [\"35018527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GNAS knockdown in HCC cells inhibits LPS-induced IL-6 expression by suppressing STAT3 activation; mechanistically, GNAS promotes STAT3 activation by inhibiting the long non-coding RNA TPTEP1 which interacts with STAT3. LPS stimulation increases GNAS expression through increased m6A methylation of GNAS mRNA.\",\n      \"method\": \"siRNA knockdown; ELISA; RNA-binding protein immunoprecipitation (RIP) for m6A; transcription factor profiling array; subcutaneous xenograft mouse model\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, mechanism inferred from indirect assays; GNAS-STAT3-TPTEP1 pathway not reconstituted directly\",\n      \"pmids\": [\"32123532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PRKDC recruits and binds GDE2 to enhance the stability of GNAS protein; elevated GNAS subsequently activates AKT phosphorylation and confers doxorubicin resistance in osteosarcoma. Combined PRKDC inhibition (AZD7648) and doxorubicin synergistically suppresses osteosarcoma growth.\",\n      \"method\": \"CRISPR kinome screen; Co-IP of PRKDC/GDE2/GNAS; protein stability assays; xenograft mouse models; human organoids\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP interaction and in vivo/organoid functional validation; single lab\",\n      \"pmids\": [\"38900943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NESP55 is preferentially localized in adrenaline-synthesizing (adrenergic) chromaffin cells of the adrenal medulla, co-localizing with phenylethanolamine-N-methyltransferase; noradrenergic cells contain ~5-fold lower levels. NESP55 mRNA distribution mirrors preproenkephalin mRNA, restricted to adrenergic cells.\",\n      \"method\": \"Immunohistochemistry of consecutive sections; radioimmunoassay; in situ hybridization\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-localization by IHC and RIA; directly establishes cell-type-specific localization\",\n      \"pmids\": [\"10218899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Oed-Sml ENU point mutation (V159E in Gnas exon 6) causes opposite parent-of-origin phenotypes: maternally transmitted mutation (via Gnas/Gsα) causes microcardia with gross edema, while paternally transmitted mutation (via Gnasxl) causes postnatal growth retardation, revealing distinct roles for Gsα in cardiac growth and XLαs in postnatal body growth.\",\n      \"method\": \"ENU mutagenesis; genetic mapping; sequencing of point mutation; uniparental transmission phenotyping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — point mutation with allele-specific phenotypes provides genetic evidence for distinct functions of each isoform; single lab\",\n      \"pmids\": [\"12376090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GNAS knockdown in INS-1 β-cells reduces insulin secretion, insulin content, and cAMP production; expression of Insulin, PDX1, and MAFA is significantly downregulated, demonstrating that Gsα/cAMP signaling is required for normal β-cell insulin secretory capacity.\",\n      \"method\": \"siRNA knockdown in INS-1 cells; insulin secretion assay; cAMP measurement; RT-PCR for β-cell transcription factors\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct loss-of-function with multiple functional readouts in a relevant cell model; single lab\",\n      \"pmids\": [\"31374326\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAS is a complex imprinted locus encoding multiple gene products from alternative first exons: Gsα (biallelically expressed in most tissues, maternally predominant in renal proximal tubules/thyroid/pituitary), XLαs (paternally expressed), and NESP55 (maternally expressed, a chromogranin-like protein in neuroendocrine secretory granules); Gsα couples GPCRs to adenylyl cyclase via a GTPase cycle (activating mutations at R201/Q227 impair GTP hydrolysis causing constitutive cAMP elevation), while XLαs and Gsα exert antagonistic effects on energy metabolism, and imprinting of the locus is controlled hierarchically by the Nespas DMR (principal ICR) and the NESP55 DMR, with the antisense Nespas lncRNA silencing Nesp via histone demethylation and subsequent DNA methylation in cis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNAS is a complex imprinted locus that produces multiple, oppositely imprinted gene products from alternative first exons within a single transcription unit, including the signaling protein Gsα, the paternally expressed XLαs, the maternally expressed neuroendocrine protein NESP55, and the paternally expressed antisense macroRNA Nespas [#0]. Gsα couples seven-transmembrane receptors to adenylyl cyclase to generate cAMP through a GTPase cycle; somatic activating mutations at R201 and Q227 impair GTP hydrolysis to cause constitutive cAMP elevation in fibrous dysplasia, McCune-Albright syndrome, and endocrine tumors, while inactivating mutations produce Albright hereditary osteodystrophy with hormone resistance restricted to maternal inheritance owing to tissue-specific maternal-predominant Gsα expression [#6]. Beyond canonical cAMP output, oncogenic Gsα signaling engages Wnt/β-catenin (via Lrp6) in fibrous dysplasia and colorectal cancer, modulates BMP-Smad-dependent osteoblast versus adipocyte fate, and a splicing-driven long isoform (Gsα-L) additionally activates ERK/MAPK signaling [#15, #16, #18, #22]. Gsα-dependent cAMP is required for β-cell insulin secretion and for melanocortin-4 receptor signaling, and receptor-selective signaling defects underlie GNAS-associated obesity [#17, #28]. The locus also exerts antagonistic metabolic control: Gsα and the paternal XLαs product have opposite effects on energy and glucose homeostasis [#7, #14]. NESP55 is a chromogranin-like acidic protein of neuroendocrine dense-core secretory granules, processed to bioactive peptides and functionally linked to noradrenergic and serotonergic neuronal systems and behavior [#1, #8]. Imprinting across the cluster is governed hierarchically by germline differentially methylated regions—the Nespas/Nesp DMRs act as principal imprinting control regions, with the antisense Nespas transcript silencing Nesp in cis through histone modification that can precede and is separable from DNA methylation [#9, #10, #11].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that the GNAS locus encodes more than Gsα by characterizing NESP55 as a neuroendocrine secretory protein, expanding the locus beyond a single signaling product.\",\n      \"evidence\": \"Molecular cloning, immunoblot, and gel electrophoresis of chromaffin granule secretory proteins\",\n      \"pmids\": [\"9111083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of NESP55-derived peptides in vivo not established\", \"Relationship to Gsα-encoding transcripts not yet defined at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Revealed that the locus is a single transcription unit producing oppositely imprinted transcripts, defining GNAS as a reciprocally imprinted cluster rather than a simple gene.\",\n      \"evidence\": \"Representational difference analysis, RT-PCR, and Northern blot in interspecific mouse crosses; plus cell-type-specific NESP55 localization in adrenergic chromaffin cells\",\n      \"pmids\": [\"10097123\", \"10218899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism enforcing parent-of-origin methylation not addressed\", \"Functional consequences of each isoform not yet tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified the paternal antisense Nespas transcript and allele-specific epigenetic features, pointing to a cis-regulatory architecture controlling imprinting.\",\n      \"evidence\": \"Strand-specific RT-PCR and Northern blot in uniparental disomy embryos; tissue-specific NESP55 splicing and PTM analysis\",\n      \"pmids\": [\"10716699\", \"10729789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal role of Nespas in silencing not yet demonstrated by perturbation\", \"Hierarchy among DMRs unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mapped allele-specific methylation and DNase I hypersensitivity to germline marks over Nespas/Gnasxl, separating their control from the Gnas promoter.\",\n      \"evidence\": \"Bisulfite sequencing and DNase I hypersensitivity across gametes, ES cells, and tissues\",\n      \"pmids\": [\"12897124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which DMR is the principal control region not resolved\", \"Mechanism linking methylation to expression switching not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the enzymatic basis of disease by showing R201/Q227 mutations impair GTPase turn-off to cause constitutive cAMP, unifying activating and inactivating phenotypes with imprinting.\",\n      \"evidence\": \"Biochemical GTPase assays, genetic analysis, and mouse knockout models\",\n      \"pmids\": [\"15331575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific effectors downstream of cAMP not enumerated\", \"Non-cAMP effector branches not yet identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated that Gsα and XLαs exert opposite effects on energy and glucose metabolism, dissociating metabolic phenotypes from a single gene product.\",\n      \"evidence\": \"Allele-specific Gnas exon deletions in mice with metabolic phenotyping; Nesp55 knockout with behavioral assays\",\n      \"pmids\": [\"15883378\", \"15798190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of XLαs antagonism of Gsα not defined\", \"Neural circuit mediating Nesp55 behavioral phenotype unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified the Nespas DMR as the principal bidirectional imprinting control region governing the entire cluster, establishing locus-wide hierarchical control.\",\n      \"evidence\": \"Paternal targeted DMR deletion in mice with allele-specific expression and methylation analysis\",\n      \"pmids\": [\"16462745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of bidirectional switching not detailed\", \"Role of antisense transcription versus the DNA element itself not separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established a second principal ICR (Nesp55 DMR) directing maternal Gnas methylation and downstream calcium/phosphate homeostasis, refining the imprinting hierarchy.\",\n      \"evidence\": \"Maternal-allele deletion mouse model with methylation, RT-PCR, and serum biochemistry\",\n      \"pmids\": [\"20427744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction between the two principal ICRs not mapped\", \"Human relevance of mouse DMR hierarchy not directly tested here\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Separated chromatin-based silencing from DNA methylation by showing Nespas silences Nesp via histone modification independent of and preceding DNA methylation.\",\n      \"evidence\": \"Nespas hypomorph knock-in with ChIP for histone marks, bisulfite analysis, and allele-specific RT-PCR\",\n      \"pmids\": [\"21455290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Histone-modifying machinery recruited by Nespas not identified\", \"Order of events in human cells not established\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked cAMP level to cell-fate decisions by showing elevated cAMP inhibits osteoblast differentiation and enhances adipogenesis via BMP-Smad blockade, connecting GNAS signaling to bone disease mechanism.\",\n      \"evidence\": \"Pluripotent mouse ES cell osteogenic differentiation with pharmacological cAMP modulation and BMP-Smad readouts\",\n      \"pmids\": [\"22903279\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro pharmacological model; in vivo relevance to fibrous dysplasia not tested here\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Used gene-dosage genetics to formally demonstrate antagonistic Gsα/XLαs actions across tissues, separating edema from the full lethal phenotype.\",\n      \"evidence\": \"Targeted mutations combined with uniparental disomy and metabolic/behavioral phenotyping\",\n      \"pmids\": [\"23822972\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific molecular targets of XLαs not identified\", \"Mechanism of dose-dependent phenotype combination unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed that Nespas transcription is necessary and sufficient for Nesp DMR methylation and that transcription can drive somatic de novo CpG methylation, defining a transcription-coupled methylation mechanism.\",\n      \"evidence\": \"Truncating and ectopic-transcription knock-in mouse alleles with bisulfite and allele-specific RT-PCR\",\n      \"pmids\": [\"29861426\", \"25659103\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methyltransferase complex coupling transcription to methylation not identified\", \"Single-lab genetic models\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated in vivo that activating GNAS R201H drives fibrous dysplasia through Wnt/β-catenin via Lrp6, providing a genetically validated effector branch and rescue target.\",\n      \"evidence\": \"Conditional knock-in mouse with histology, Western blot, and Lrp6 heterozygosity rescue\",\n      \"pmids\": [\"29158412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from cAMP/PKA to Wnt activation not fully defined\", \"Generality across other GNAS-driven tissues not tested here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded GNAS signaling to context-specific tumor behavior and β-cell function, showing PKA-dependent NOTCH regulation in pancreatic cancer and cAMP-dependent insulin secretion.\",\n      \"evidence\": \"CRISPR R201H manipulation with xenografts and NICD analysis; siRNA knockdown in INS-1 β-cells with secretion and transcription factor readouts\",\n      \"pmids\": [\"35018527\", \"31374326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab models for each context\", \"Direct PKA-NOTCH and PKA-β-cell transcription factor links not biochemically reconstituted\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Explained clinical heterogeneity of GNAS-associated obesity by showing mutations differentially impair MC4R, GHRHR, and TSHR signaling, linking receptor-selective cAMP defects to phenotype.\",\n      \"evidence\": \"Exome sequencing with receptor-specific cAMP signaling assays and genotype-phenotype correlation in a patient cohort\",\n      \"pmids\": [\"34614324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for receptor-selective coupling defects not resolved\", \"Tissue-level integration of multiple receptor defects not modeled\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed non-cAMP and isoform-specific oncogenic mechanisms: splicing-driven Gsα-L activates ERK/MAPK, and R201 mutations drive β-catenin in colorectal cancer with oncogene addiction.\",\n      \"evidence\": \"RNA-seq/eCLIP in isogenic iPSC-derived HSPCs with biochemical assays and MEK inhibitor sensitivity; CRISPR GNAS knockout in CRC with organoid/xenograft and PKA/β-catenin inhibition\",\n      \"pmids\": [\"34620690\", \"35879396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Switch determining cAMP versus ERK output not defined\", \"Relative contribution of Wnt versus PKA in CRC growth not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined human imprinting architecture by showing the NESP-ICR controls A/B silencing and the STX16-ICR acts as a pluripotency-factor-dependent long-range enhancer of NESP55, and identified GPR176 as an intracellular Gsα-recruiting receptor controlling mitophagy.\",\n      \"evidence\": \"CRISPR ICR deletions in hESCs with allele-specific methylation/expression and ChIP; Co-IP and domain modeling with cAMP/mitophagy assays and CRC mouse models\",\n      \"pmids\": [\"36853809\", \"36905238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conservation of STX16-ICR enhancer mechanism in non-embryonic tissues unclear\", \"GPR176/GNAS interaction validated by single-lab Co-IP and modeling\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected GNAS protein stability to chemoresistance by showing a PRKDC-GDE2 axis stabilizes GNAS to drive AKT activation and doxorubicin resistance in osteosarcoma.\",\n      \"evidence\": \"CRISPR kinome screen, Co-IP of PRKDC/GDE2/GNAS, stability assays, xenografts, and organoids\",\n      \"pmids\": [\"38900943\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which PRKDC/GDE2 stabilizes GNAS not defined\", \"Single lab; interaction not reciprocally validated across systems\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Gsα output is partitioned between cAMP/PKA, Wnt/β-catenin, and ERK/MAPK branches across tissues, and how the imprinting hierarchy and isoform antagonism are integrated into human disease, remains incompletely resolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking receptor identity to effector branch selection\", \"Molecular machinery coupling Nespas transcription to methylation not identified\", \"Mechanistic basis of Gsα/XLαs metabolic antagonism unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [6, 17, 20]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [11, 12, 13]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 20]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 26]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 17, 18, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 11, 19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5, 11]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 15, 17, 22]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 14, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GPR176\", \"LRP6\", \"PRKDC\", \"GDE2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}